Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Revenues, Income Rise for Q2

NEW YORK, July 28 (GenomeWeb News) - Thermo Electron reported increased revenues and income late yesterday, including an 18 percent increase in revenue for its Life and Laboratory Sciences segment.

 

The company's income totaled $91 million on revenues of $525 million, compared to $53.1 million in income on revenues of $467 million in the same period last year. The second-quarter revenues for the life and laboratory sciences segment came to $370 million, versus $314 million for the year-ago quarter.

 

R&D expenses were flat, at $32.6 million, compared to the same amount for the second quarter of 2003.

 

As of July 3, the company had $306.6 million in cash and cash equivalents, compared to $303.9 million in the second quarter of last year.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.